Motilal Oswal Alternates invests USD 72 mn in Sensa Core Medical Instrumentation,
taking a significant minority stake in an innovation-drivenmedical devices’ company
Mumbai,December 22, 2025: Motilal Oswal Alternates is pleased to announce a significantminority investment of USD 72 million in Sensa Core, an innovation drivenmedical devices’ company focused on advancing healthcare technology in India.This partnership underscores our commitment to support indigenous healthcaresolutions that promise to transform patient outcomes.
Founded in Hyderabad in 2006, SensaCore is engaged in design (IP-driven), development, manufacturing anddistribution of specialized in-vitro diagnostic devices. Started as a fullybootstrapped venture, the Company has evolved into a market leader in ElectrolyteAnalysers, achieving wide adoption across more than 40,000 hospitals/diagnosticlabs in India and exports to over 78 countries. Sensa Core is also one of theleading Indian players in Glucometers, Haemoglobin meters and has recentlyforayed in Arterial Blood gas Analysers. The Company operates a dedicated manufacturingfacility in Hyderabad’s Export Promotion Industrial Park, Pashamylaram and willbe commissioning a new manufacturing facility in Medical Device Park,Sultanpur, Hyderabad to augment capacity & build capability for newproducts.
The Company is founded by Dr. RaviKumar Meruva, Ph.D., and a technocrat entrepreneur with deep domain expertiseand 30+ years of experience in electrochemistry, system design and appliedmedical technology. The investment will enable Sensa Core to accelerateproduct development and expand its footprint globally, further strengtheningits position as one of the leading players in the IVD segment.
Commenting on this announcement,Mr. Rohit Mantri, Managing Director andCo-Head of Private Equity at Motilal Oswal Alternates said, “India imports over 75% of its medical devices, with annualimports exceeding USD 8.5 billion... worldwide.”
Sensa Core was advised by Veda CorporateAdvisors on the transaction.
For further details, contact: